Longevity News

Michael Polansky is training an AI model on skin that’s still alive

Source: TechCrunch • Published: 22 Aug 2026, 01:31

Michael Polansky is training an AI model on skin that’s still alive

Report on a startup combining living human skin tissue maintenance with AI to accelerate discovery of new topical cosmetic compounds and testing workflows.

Key Takeaways
  • Both the founder of a buzzy AI and biology startup called Outer Biosciences and the creative
  • He logged three years at the hedge fund Bridgewater Associates — “a very unique place,” Polansky says over coffee
  • (Both outfits receive federal funding from the NIH and the National Cancer Institute without being federally operated.)
Read Original Source

Continue exploring

Related longevity signals

Fight Aging!Senescent Microglia Secrete DLK1, Which Causes Dysfunction in the Aging BrainExamines how senescent microglia secrete a soluble Notch ligand that impairs oligodendrocytes and neuronal function in aging brains.Longevity TechnologyMinicircle named XPRIZE Healthspan finalistMinicircle’s XPRIZE Healthspan finalist status — a brief look at a gene‑therapy developer advancing to late-stage competition with plans for human trials.Longevity TechnologyUnited Therapeutics seeks FDA approval for inhaled treatment for idiopathic pulmonary fibrosisAn article previewing news about a pharmaceutical company's regulatory submission for an inhaled therapy for a chronic lung condition, inviting readers to learn more about the filing and clinical trial context.Frontiers - HealthHAMSIAA protects cyclophosphamide induced immunosuppression by modulating gut homeostasis and purine metabolismReports preclinical evidence that a colon-targeted indole-3-acetic acid starch derivative preserves immune organ integrity and gut barrier function in chemotherapy-treated mice.